Retrovirally transduced antisense sequences stably suppress P210BCR-ABL expression and inhibit the proliferation of BCR/ABL-containing cell lines.

作者: P Martiat , P Lewalle , AS Taj , M Philippe , Y Larondelle

DOI: 10.1182/BLOOD.V81.2.502.502

关键词:

摘要: There is now strong evidence that the BCR-ABL gene product of Philadelphia chromosome (P210) plays a crucial role in pathogenesis chronic myeloid leukemia (CML). We have previously shown introduction antisense oligonucleotides into K562 cells could transiently block expression P210 and specifically inhibit cellular growth culture. In this report, we describe use retroviral vector to introduce selected sense sequences, first murine B10 cells, rendered interleukin-3 (IL-3) independent by transfection second cells. The transcripts generated under control MoMLV promoter killed absence IL-3 inhibited almost completely. sequences led dramatic reduction increased their doubling time more than twofold. This effect was not reversed addition exogenous culture medium. Control HeLa or HL60 infected with same constructs did show any change proliferation rate, despite abrogation normal BCR products. Rather unexpectedly, suppression lethal showing such cell line does rely entirely on for surviving, but depends it as far properties are concerned. conclude approach can successfully achieve stable oncogenic protein may be used study further mechanisms which transforming fresh CML bone marrow cultures remains assessed before tell whether technique selective leukemic hematopoiesis vitro.

参考文章(18)
P. C. Nowell, A minute chromosome in human chronic granulocytic leukemia Science. ,vol. 132, pp. 1497- ,(1960)
D Markowitz, S Goff, A Bank, A safe packaging line for gene transfer: separating viral genes on two different plasmids. Journal of Virology. ,vol. 62, pp. 1120- 1124 ,(1988) , 10.1128/JVI.62.4.1120-1124.1988
M Kelliher, A Knott, J McLaughlin, O N Witte, N Rosenberg, Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene. Molecular and Cellular Biology. ,vol. 11, pp. 4710- 4716 ,(1991) , 10.1128/MCB.11.9.4710
Nora Heisterkamp, Guido Jenster, Joanne ten Hoeve, Daniel Zovich, Paul K. Pattengale, John Groffen, Acute leukaemia in bcr/abl transgenic mice Nature. ,vol. 344, pp. 251- 253 ,(1990) , 10.1038/344251A0
P. Martiat, D. Maisin, M. Philippe, A. Ferrant, J. L. Michaux, J. J. Cassiman, H. Berghe, G. Sokal, Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primers British Journal of Haematology. ,vol. 75, pp. 355- 358 ,(1990) , 10.1111/J.1365-2141.1990.TB04348.X
C Szczylik, T Skorski, N. Nicolaides, L Manzella, L Malaguarnera, D Venturelli, A. Gewirtz, B Calabretta, Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides Science. ,vol. 253, pp. 562- 565 ,(1991) , 10.1126/SCIENCE.1857987
Andrew P. Feinberg, Bert Vogelstein, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity Analytical Biochemistry. ,vol. 132, pp. 6- 13 ,(1983) , 10.1016/0003-2697(83)90418-9
J GROFFEN, J STEPHENSON, N HEISTERKAMP, A DEKLEIN, C BARTRAM, G GROSVELD, Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 Cell. ,vol. 36, pp. 93- 99 ,(1984) , 10.1016/0092-8674(84)90077-1
Lesley C. Walker, Trivadi S. Ganesan, Susheela Dhut, Barbara Gibbons, T. Andrew Lister, Jonathan Rothbard, Bryan D. Young, Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia. Nature. ,vol. 329, pp. 851- 853 ,(1987) , 10.1038/329851A0